SCHEMBL9739141

SCHEMBL9739141

CC(C)(C)Cn1nc(C(=O)NC2CCCCC2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.37
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CNR2 P34972 6/20 0.34
CNR1 P21554 5/20 0.34
FAAH O00519 3/20 0.34
ABHD12 Q8N2K0 2/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
SLC33A1 O00400 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739505 0.99 RIPK1 (0.37) RIPK1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738796 0.90 AGTR1 (0.38) RIPK1SLC33A1
SCHEMBL9740009 0.89 AGTR1 (0.39) RIPK1
SCHEMBL9739090 0.89 AGTR1 (0.44) CNR2CNR1
SCHEMBL9738079 0.88 RIPK1 (0.34) RIPK1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738675 0.88 SLC33A1 (0.36) RIPK1SLC33A1
SCHEMBL9738627 0.88 AGTR1 (0.44)
SCHEMBL9738099 0.87 RIPK1 (0.35) RIPK1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738918 0.86 SLC33A1 (0.34) RIPK1SLC33A1
SCHEMBL9738503 0.86 TRPV1 (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed